A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.
Edwards Lifesciences' state-of-the-art heart valves have a big growth runway. Abbott Laboratories has received several encouraging FDA approvals recently.
All three of these dividend stocks have paid a growing dividend for more than 25 years each

My Dividend Growth Portfolio - Q1 2023 Summary

01:26am, Thursday, 06'th Apr 2023
In 2015, I started publishing updates regarding my dividend growth portfolio, and I keep doing so every quarter. This is part of being transparent with my readers, so they can see what I hold and its
CVS Health is famous for its retail business, but it's just a small part of its increasingly profitable operation. UnitedHealth Group is a health insurance benefits manager that provides more of the b

6 April Dividend Kings To Buy, 5 To Watch

03:19pm, Friday, 31'st Mar 2023
"There is only one-criterion to be included among the Dividend Kings: A publicly-traded company must increase its total fiscal-year dividend payout for a minimum of 50 consecutive years." - Dogs of th
Abbott's (ABT) Epic Max design optimizes patient blood flow and has a low profile that makes future cardiac interventions simpler.
In 2022, healthcare stocks surpassed the S&P 500. But in 2023, they are not doing so well.

My Best Dividend Aristocrats For April 2023

03:54pm, Thursday, 30'th Mar 2023
NOBL gave up a big chunk of its January gains in February, finishing the month down 2.36%. March has seen the ETF tumble some more as it's down 1.88% through 3/29. I present 3 strategies that can theo
Most people are far behind on their retirement goals - often without realizing it. In this article, I present conservative dividend growth investing as a suitable way to achieve long-term financial go
I propose leveraging the stock selection criteria from the underlying index of SCHD to build a portfolio with a subset of Dividend Aristocrats. I am tracking two portfolios built using this process an
Pfizer is in the process of pumping out new products to help replace its coronavirus lineup. Abbott has a diversified business centered around its highly successful medical devices unit.
Abbott (ABT) announces key findings from meta-analysis, which shows remote pressure monitoring to be a life-extending option among heart failure patients.
According to the average brokerage recommendation (ABR), one should invest in Abbott (ABT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommend
Investors are optimistic about Abbott (ABT) on continued growth in the core Diagnostics arm.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE